Skip to main content

Table 2 Cause-specific hazard ratio (HR) comparing CRT versus RT for each competing event based on the logrank test

From: Analysis and design of randomised clinical trials involving competing risks endpoints

Variables O E Unadjusted HR (95% CI) p-value
M : Distant metastasis     
   RT 38 26.54 0.43 (0.25 - 0.72) 0.002
   CRT 18 29.46 1.00  
R : Loco-regional recurrence     
   RT 10 9.19 0.84 (0.34 - 2.07) 0.711
   CRT 9 9.81 1.00